Pfizer To Supply 6M COVID-19 Therapy Courses To Low Income Countries

Pfizer Inc PFE would supply up to 6 million courses of its COVID-19 antiviral treatment to NGO Global Fund for low- and middle-income countries.
The company said Paxlovid treatment courses would be available for procurement through Global Fund's COVID-19 Response Mechanism to 132 low- and middle-income countries this year, subject to local regulatory clearances.
Eligible countries will be offered treatment courses according to Pfizer's tiered pricing approach, where all low- and lower-middle-income countries will pay a not-for-profit price.
Also Read: Pfizer's COVID-19 Pill Benefited Only Older Adults, New Israel-Based Study Shows.
Additional contractual details of the agreement were not disclosed.
Pfizer has made a deal with several generic drugmakers to produce its treatment at a lower price for developing countries.
"This agreement with Global Fund is a critical step that will boost equitable access for high-risk patients in low-and-middle-income countries," Chief Executive Officer Albert Bourla said in a statement.
Price Action: PFE shares are up 1.24% at $44.47 on the last check Thursday.
Photo via Wikimedia Commons

Momentum31.78

Growth78.65

Quality52.43

Value30.84

Short

Medium

Long